Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells-Reference-Cited by-同舟云学术

Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells

Published:2018-07-25 Issue:1 Volume:37 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Mukherjee Sumit^ORCID,Fried Angela,Hussaini Rahman,White Richard,Baidoo Juliet,Yalamanchi Sri,Banerjee Probal^ORCID

Funder

PSC-CUNY

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-018-0792-5.pdf

Reference90 articles.

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. European organisation for R, treatment of Cancer brain T, radiotherapy G, National Cancer Institute of Canada clinical trials G: radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.

2. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492–507.

3. Wick W, Platten M, Weller M. New (alternative) temozolomide regimens for the treatment of glioma. Neuro-Oncology. 2009;11(1):69–79.

4. Neyns B, Chaskis C, Joosens E, Menten J, D'Hondt L, Branle F, Sadones J, Michotte A. A multicenter cohort study of dose-dense Temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or Oligoastrocytoma. Cancer Investig. 2008;26:269–77.

5. Su YB, Sohn S, Krown SE, Livington PO, Wolchek JD, Quinn C, Williams L, Foster T, Sepkowitz KA, Chapman PB. Selective CD4 Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic Implications. J Clin Oncol. 2004;22:610–6.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transgenerational hormesis in healthy aging and antiaging medicine from bench to clinics: Role of food components;Mechanisms of Ageing and Development;2024-08

2. Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment;Journal of Advanced Research;2024-08

3. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies;Cancer Letters;2024-07

4. A comprehensive review on the use of traditional Chinese medicine for cancer treatment;Pharmacological Research - Modern Chinese Medicine;2024-06

5. Emerging Techniques for Herbosomes;Dosage Forms - Emerging Trends and Prospective Drug-Delivery Systems [Working Title];2024-05-28